Formulation Guide
Sublingual
Under-tongue vascular absorption
This tool shows mechanism, verdict, and alternative data only — not patient-specific advice. A “can crush” result is a general guide, not a guarantee for your exact product: the same ingredient can differ by brand, manufacturer, and formulation. Data comes from U.S. drug labels and covers a limited set of medicines — if a drug isn’t listed, that is not a green light to crush it. Always confirm with your pharmacist or physician before altering how a medication is administered.
How it works
Sublingual formulations are designed to dissolve rapidly under the tongue, allowing drug absorption through the highly vascularized sublingual mucosa directly into the systemic circulation, bypassing hepatic first-pass metabolism. This route achieves rapid onset (minutes) and higher bioavailability for drugs with extensive first-pass extraction compared with swallowed oral dosage forms. Examples include sublingual glyceryl trinitrate and buprenorphine.
Why crushing or splitting is risky
Sublingual tablets are already designed for fast, local dissolution. Crushing is generally unnecessary and risks altering drug particle size in ways that affect mucosal absorption kinetics. More importantly, swallowing the crushed powder negates the bypass of first-pass metabolism, dramatically reducing bioavailability for drugs like buprenorphine and increasing it unpredictably for others, which can result in inadequate therapeutic effect or unintended systemic toxicity.